HARTMANN USA Expands Advanced Wound Care Portfolio Through Exclusive Distribution Agreement with SweetBio®

Agreement expands clinician and patient access to SweetBio's collagen and Mānuka honey technology through HARTMANN's national sales team.

ROCK HILL, S.C., October 1st, 2026 – HARTMANN USA, Inc. announced an exclusive national commercial distribution agreement with SweetBio®, a biotechnology company pioneering bioengineered wound care solutions. Through the agreement, HARTMANN USA will become the exclusive nationwide commercial distribution partner for VERIS™, SweetBio®'s advanced wound care product. VERIS™ is intended for the management of acute and chronic wounds and uniquely features collagen derivative and Mānuka honey in a patented formulation.

SweetBio is a medical device company bioengineering honey into wound care products. It is led by sibling duo Kayla Rodriguez Graff, Chief Executive Officer, and Dr. Isaac Rodriguez, Chief Science Officer. SweetBio is a 2015 graduate of the ZeroTo510 medical device accelerator, and is currently headquartered at the University of Memphis CommuniTech Research Park. They are committed to making their products accessible to all patients, and are voices in the movement to make startup economies more diverse and inclusive. They are advocates for the Memphis entrepreneurship ecosystem, and can often be found at regional and national entrepreneurship events. Rodriguez Graff also serves on Epicenter’s Board of Directors.

A Preliminary Direct Comparison of the Inflammatory Reduction and Growth Factor Production Capabilities of Three Commercially Available Wound Products: Collagen Sheet, Manuka Honey Sheet, and a Novel Bioengineered Collagen Derivative + Manuka Honey + Hydroxyapatite Sheet

Physician Dr. Josephine Lyons shares patient’s success story using APIS®

Medical device company Sweetbio is looking to help revolutionize first aid with its manuka honey-based wound care product.

Featured on HOLA!

Featured on Apple

INC. Founder Profile

Featured on Forbes